Form 4: Guardian Pharmacy Exec Converts First Tranche of Class B Stock
Insider Transaction Report
Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the first of three automatic conversions of 608,570 Class B common shares into Class A common shares.
Summary
- Kendall Forbes, Executive Vice President, Sales & Operations at Guardian Pharmacy Services, Inc. (GRDN), reported an automatic conversion of equity securities.
- On September 27, 2025, 608,570 shares of Class B common stock were automatically converted into an equal number of Class A common stock.
- This transaction represents the first of three substantially equal tranches of conversion, as per the Issuer's Amended and Restated Certificate of Incorporation.
- Following this conversion, Kendall Forbes beneficially owns 812,476 shares of Class A common stock and 1,217,140 derivative Class B common stock.
- The remaining Class B shares are scheduled to convert on March 28, 2026, and September 27, 2026.
Sentiment
Score: 5
Explanation: The transaction is a pre-scheduled, automatic conversion of equity, not a discretionary buy or sell, indicating a neutral sentiment regarding immediate company prospects.
Positives
- The conversion increases the liquidity of the executive's holdings by transforming Class B shares into more readily tradable Class A shares.
- The pre-scheduled nature of the conversion provides transparency regarding future share structure changes.
Negatives
- No direct negative implications are evident from this routine, pre-scheduled conversion.
Future Outlook
Future automatic conversions of Class B common stock into Class A common stock are scheduled for March 28, 2026, and September 27, 2026, in substantially equal tranches.
Management Comments
- Kendall Forbes holds the position of Executive Vice President, Sales & Operations.
Industry Context
This filing reports a routine insider transaction specific to Guardian Pharmacy Services, Inc. and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Structure | The automatic conversion of Class B common stock to Class A common stock is mandated by the Issuer's Amended and Restated Certificate of Incorporation, outlining a pre-defined equity conversion schedule. | 09/27/2025 | This mechanism provides a structured pathway for converting less liquid Class B shares into more liquid Class A shares over time, impacting the company's share float and insider holdings. |
Stakeholder Impact
- Shareholders: The conversion will gradually increase the float of Class A common stock available in the market over time.
- Executive (Kendall Forbes): The conversion enhances the liquidity of the executive's equity holdings by transforming Class B shares into more tradable Class A shares.
Next Steps
- The remaining Class B common stock held by the reporting person will automatically convert into Class A common stock in two additional substantially equal tranches on March 28, 2026, and September 27, 2026.
Key Dates
| Date | Description |
|---|---|
| 09/27/2025 | Date of the first tranche conversion of Class B to Class A common stock. |
| 09/30/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 03/28/2026 | Scheduled date for the second tranche conversion of Class B to Class A common stock. |
| 09/27/2026 | Scheduled date for the third tranche conversion of Class B to Class A common stock. |
Recommendation
holdThis Form 4 reports a routine, pre-scheduled automatic conversion of Class B common stock to Class A common stock by an executive. It does not represent a discretionary investment decision or signal a change in the company's fundamental outlook, thus warranting a neutral 'hold' recommendation.
Keywords
Guardian Pharmacy Services, GRDN, Kendall Forbes, Form 4, stock conversion, Class A common stock, Class B common stock, insider transaction, beneficial ownership, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.